KCNQ1 gene mutations and the respective genotype-phenotype correlations in the long QT syndrome

Medical Science Monitor

Volumn 8, Issue 10, 2002, Pages

  Herbert, Ernest ^a   Trusz Gluza, Maria ^a   Moric, Ewa ^a   Śmiłowska Dzielicka, Ewa ^a   Mazurek, Urszula ^a   Wilczok, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Arrhythmia; Long QT syndrome; Mutation; Potassium channels

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NICORANDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; KCNQ1 PROTEIN, HUMAN; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ1; VOLTAGE GATED POTASSIUM CHANNEL;

CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; ELECTROCARDIOGRAM; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE STRUCTURE; GENOTYPE PHENOTYPE CORRELATION; HEART ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MISSENSE MUTATION; REVIEW; RISK; CHEMISTRY; ELECTROCARDIOGRAPHY; GENETICS; GENOTYPE; METABOLISM; MUTATION; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN SECONDARY STRUCTURE;

ELECTROCARDIOGRAPHY; GENOTYPE; HUMANS; KCNQ POTASSIUM CHANNELS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MUTATION; PHENOTYPE; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN STRUCTURE, SECONDARY;

EID: 0036775079     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Dumaine R, Antzelevitch C: Molecular mechanisms underlying the long QT syndrome. Curr Opin Cardiol, 2002; 17: 36-42
2. Priori SG, Barhanin J, Hauer NW et al: Genetic and molecular basis of cardiac arrhythmias. Study Group on the molecular basis of arrhythimas of the Working Group on arrhythmias of the European Society of Cardiology. Eur Heart J, 1999; 20: 174-195
3. Khan IA: Long QT syndrome, diagnosis and management. Am Heart J, 2002; 143: 7-14
4. Keating M, Atkinson D, Dunn C et al: Linkage of cardiac arrhythmia, the long QT syndrome and the Harvey ras-1 gene. Science, 1991; 252: 704-706
5. Chiang C, Roden DM: The Long QT Syndromes: Genetic basis and clinical implications. J Am Coll Cardiol, 2000; 36: 1-12
6. Shimiztl W, Antzelevitch C: Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2 and LQT3 models of the Long QT Syndrome. Circulation, 2000; 102: 706-712
7. Antzelevitch C, Schimizu W: Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol, 2002; 17: 43-51
8. Jervell A, Lange-Nielsen F: Congenital deaf mutism, functional heart disease with prolongation of the QT interval and sudden death. Am Heart J, 1957; 54: 59-78
9. Romano C: Congenital cardiac arrhythmia. (Letter) Lancet, 1965; 658-659
10. Ward OC: A new familial cardiac syndrome in children. J Irish Med Assoc. 1964; 54: 103-106
11. Wang Q, Curran ME, Splawski I et al: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet, 1996; 12: 17-23
12. Vincent GM, Timothy KW, Leppert M, Keating M: The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. New Engl J Med, 1992; 327: 846-852
13. Priori SG, Bloise R, Crotti L: The long QT syndrome. Europace, 2001; 3: 16-27
14. Tristani-Firouzi M, Chen J, Mitcheson JS, Sanguinetti MC: Molecular biology of K(+) channels and their role in cardiac arrhythmias. Am J Med, 2001; 110: 50-59
15. Splawski I, Shen J, Timothy KW et al: Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation, 2000; 102: 1178-1185
16. Yue L, Feng J, Li GR, Nattel S: Characterization of an ultrarapid delayed rectifier potassium channel involved in canine atrial repolarization. J Physiol, 1996; 496: 647-62
17. Fedida D. Wible B. Wang Z et al: Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res, 1993; 73: 210-216
18. Nattel S, Wang Z, Fermini B: Three types of delayed rectifier potassium currents in human atrial cardiomyocytes. Biophys J, 1993; 64: A393
19. Sanguinetti MC: Modulation of potassium channels by antiarrhythmic and anti-hypertensive drugs. Tutorial in molecular and cellular biology hypertension. Hypertension, 1999; 19: 228-236
20. Sanguinetti MC, Jurkiewicz NK: Delayed rectifier K+ channels of cardiac muscle. In: Spooner PM, Brown AM, Catterall WA, et al, eds. Ion Channels in the Cardiovascular System: Function and Dysfunction. Armonk: Futura Publishing Company, 1994
21. Busch AE, Suessbrich H, Waldegger S et al: Inhibition of IKS in guinea pig cardiac myocytes and guinea pig ISK channels by the chromanol 293B. Eur J Physiol, 1996; 432: 1094-1096
22. Vatta M, Li H, Towbin JA: Molecular biology of arrhythmic syndromes. Curr Opin Cardiol, 2000; 15: 12-22
23. Wollnik B, Schroeder BC, Kubisch C et al: Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet, 1997; 6: 1943-1949
24. Li H, Chen Q, Moss AJ et al: New mutations in the KVLQT1 potassium channel that cause long QT syndrome. Circulation, 1998; 97: 1264-1269
25. Huang L, Bitner-Glindzicz M, Tranebjaerg L, Tinker A: A spectrum of functional effects for disease-causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res, 2001; 51: 670-680
26. Kaufman ES, Priori SG, Napolitano C et al: Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome J Cardiovasc Electrophysiol, 2001; 12: 445-461
27. Vincent GM: Role of DNA testing for diagnosis, management and screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome. Heart, 2001; 86: 12-14
28. Schwartz PJ, Moss AJ, Vincent GM: Crampton RS. Diagnostic criteria for the long QT syndrome: An update. Circulation, 1993; 88: 782-784
29. Priori SG, Napolitano C, Schwartz PJ: Low penetrance in the long QT syndrome: Clinical impact. Circulation, 1999; 99: 529-533
30. Priori SG, Allot E: Blomstrom-Lundqvist C et al: Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J, 2001; 22: 1374-450
31. Zareba W, Moss AJ, Schwartz PJ et al: Influence of the genotype on the clinical course of the Long QT syndrome. N Engl J Med, 1998; 339: 960-965
32. Zhang L, Timothy KW, Vincent GM et al: Spectrum of ST-T wave patterns and repolarization parameters in congenital Long QT syndrome: ECG findings identify genotypes. Circulation, 2000; 102: 2849-2855
33. Moss AJ, Zareba W, Benhorin J et al: ECG T-wave patterns in genetically distinct forms of the hereditary Long QT syndrome. Circulation, 1995; 92: 2929-2934
34. Schwartz PJ, Priori SG, Spazzolini C et al: Genotype-phenotype correlation in the Long QT Syndrome. Circulation, 2001; 103: 89-95
35. Wilde AAM, Jongbloed RJE, Doevendans PA et al: Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KvLQT1-related patients (LQTS1). J Am Coll Cardiol, 1999; 33: 327-332
36. Paavonen K, Swan H, Piippo K et al: Response of the QT interval to mental and physical stress in types LQT1 and LQT2 of the Long QT syndrome. Heart, 2001; 86: 39-44
37. Tanabe Y, Inagaki M, Kurita T et al: Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital Long QT Syndrome. J Am Coll Cardiol, 2001; 37: 911-919
38. Shimizu W, Antzelevitch C: Cellular basis for the ECG features of the LQT1 form of the Long QT Syndrome: Effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes, Circulation, 1998; 98: 2314-2322
39. Moss AJ, Zareba W, Hall WJ et al: Effectiveness and limitations of beta-blocker therapy in congenital Long QT syndrome. Circulation, 2000; 101: 616-623
40. Sato T, Hata Y, Yamamoto M et al: Early after-depolarization abolished by potassium channel opener in patients with idiopathic Long QT syndrome. J Cardiovasc Electrophysiol, 1995; 6: 279-282
41. Salata JJ, Jurkiewicz NK, Wang J et al: A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents. Mol Pharmacol, 1998; 54: 220-230
42. Tanaka T, Nagai R, Tomoike H et al: Four novel KVLQT1 and four novel HERG mutations in familial long QT syndrome. Circulation, 1997; 95: 565-567
43. Russell MW, Dick MII, Collins FS, Brody LC: KVLQT1 mutations in three families with familial or sporadic Long QT syndrome. Hum Mol Genet, 1996; 5: 1319-1324
44. Neyroud N, Tesson F, Denjoy I et al: A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and LangeNielsen cardioauditory syndrome. Nature Genet, 1997; 15: 186-189
45. Ackerman MJ, Schroeder JJ, Berry R et al: A novel mutation in KVLQT1 is the molecular basis of inherited Long QT syndrome in a near-drowning patient's family. Pediatr Res, 1998; 44: 148-153
46. Jongbloed RJE, Wilde AAM, Geelen JL et al: Novel KCNQ1 and HERG missense mutations in Dutch long QT families. Hum Mutat, 1999; 13: 301-310
47. Neyroud N, Richard P, Vignier N: Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the Long QT syndrome. Circ Res, 1999; 84: 290-297
48. Ackerman MJ, Tester DJ, Porter CJ, Edwards WD: Molecular diagnosis of the inherited Long QT syndrome in a woman who died after near drowning. N Engl J Med, 1999; 341: 1121-1125
49. Chen Q, Zhang D, Gingell RL et al: Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation, 1999; 99: 1344-1347
50. Larsen LA, Fosdal I, Andersen PS et al: Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene. Eur J Hum Genet, 1999; 7: 724-728
51. Donger C, Denjoy I, Berthet M et al: KVLQT1 C-terminal missense mutation causes a forme fruste Long QT syndrome. Circulation, 1997; 96: 2778-2781
52. Splawski I, Shen J, Timothy KW et al: Genomic structure of three Long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics, 1998; 51: 86-97
53. Tyson J, Tranebjaerg L, Bellman S et al: 1sK and KVLQT1: Mutation in either of the two sub-units of the slow component of the delayed rectifier potassium channel can cause Jervell and LangeNielsen syndrome. Hum Mol Genet, 1997; 12: 2179-2185
54. Priori SG, Napolitano C, Schwartz PJ: Low penetrance in the Long QT syndrome: Clinical impact, Circulation, 1999; 99: 529-533
55. Itoh T, Tanaka T, Nagai R: Genomic organization and mutational analysis of KVLQT1, a gene responsible for familial Long QT syndrome. Hum Genet, 1998; 102: 435-439
56. Saarinen K, Swan H, Kainulainen K et al: Molecular genetics of the Long QT Syndrome: Two novel mutations of the KVLQT1 gene and phenotype expression of the mutant gene in a large kindred. Hum Mutat, 1998; 11: 158-165
57. Priori SG, Schwartz PJ, Napolitano C et al: A recessive variant of the Romano-Ward Long QT syndrome? Circulation, 1998; 97: 2420-2425
58. Chouabe C, Neyroud N, Guicheney P et al: Properties of KVLQT1 potassium channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J, 1997; 16: 5472-5479
59. Murray A, Donger C, Fenske C et al: Splicing mutations in KCNQ1: A mutation hot spot at codon 344 that produces in frame transcripts. Circulation, 1999; 100: 1077-1084
60. Berthet M, Denjoy I, Donger C et al: The Role of Hypokalemia and a KCNQ1-Associated Mutation in Cardiac Event Occurrence. Circulation, 1999; 99: 1464-1470
61. Russell MW, Dick MII, Collins FS, Brody LC: KVLQT1 mutations in three families with familial or sporadic Long QT syndrome. Hum Mol Genet, 1996; 5: 1319-1324
62. Kanters JK, Larsen LA, Orholm M et al: Novel donor splice site mutation in the KVLQT1 gene is associated with the Long QT syndrome. J Cardiovasc Electrophysiol, 1998; 9: 620-624